儿童病毒性脑炎辅助中成药治疗的多中心回顾性研究
本研究回顾性纳入2018至2021年五家医疗机构住院的834例儿童病毒性脑炎患者,评估辅助中成药(CPM)对结局的影响。多因素logistic回归显示CPM使用是后遗症发生的独立保护因素(OR=0.063,95%CI 0.011-0.350,p=0.002),亚组分析一致。CPM组患儿病程、发热和头痛持续时间更短,结论提示辅助CPM可能减少后遗症并缓解症状,但需更多前瞻性研究验证。
要点
- 辅助中成药治疗后遗症更少,多因素分析显示为独立保护因素(OR=0.063)。
- 无论是否昏迷或合并症,中成药对后遗症均有保护作用。
- 中成药组患儿病程、发热及头痛持续时间更短。
核心结论
- 辅助中成药治疗可能显著减少儿童病毒性脑炎后遗症,并有效缓解临床症状。
- 需更多前瞻性研究和临床试验进一步评估其疗效与安全性。
研究设计与样本
- 多中心回顾性研究,纳入2018至2021年五家医疗机构住院的834例病毒性脑炎患儿。
- 采用单因素和多因素logistic回归评估中成药对后遗症的影响,并用1:1倾向性评分匹配排除混杂因素。
主要发现
- 无论是否匹配,使用中成药组后遗症患者均较少。
- 多因素logistic回归显示中成药使用是病毒性脑炎后遗症发生的独立保护因素(OR=0.063,95%CI 0.011-0.350,p=0.002)。
- 亚组分析显示,无论有无昏迷和合并症,中成药均为后遗症的保护因素。
- 中成药组患儿病程、发热和头痛持续时间更短。
临床怎么用
- 在儿童病毒性脑炎治疗中,可考虑辅助使用中成药以降低后遗症风险并缩短病程。
- 临床应用需结合患儿具体情况,并关注后续前瞻性研究证据。
局限性
- 本研究为回顾性研究,可能存在选择偏倚和信息偏倚。
- 需更多前瞻性研究和临床试验进一步验证疗效与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some patients with viral encephalitis in China seek treatment with Chinese patent medicine (CPM) to improve their symptoms, but few studies have focused on the impact of CPM on the prognosis of viral encephalitis (VE). The aim of this multicenter retrospective study was to assess the benefit of adjunctive CPM therapy on the outcome of children with VE in China. METHODS: This study retrospectively included 834 children with viral encephalitis who were hospitalized at five medical institutions from 2018 to 2021. Univariate and multivariate logistic regression was used to assess the effect of CPM on sequelae in patients with VE. 1:1 propensity score matching was used to exclude the effect of confounding factors. Forest plots were used to observe the effect of CPM on the prognosis of VE in different subgroups. RESULTS: There were fewer patients with sequelae in the group of patients using CPM regardless of whether they were matched or not. The results of multivariate logistic regression analysis showed that the use of CPM was an independent protective factor for the development of sequelae in VE patients (OR = 0.063, 95 % CI: 0.011-0.350, p = 0.002). Subgroup analyses showed that CPM was a protective factor for the development of sequelae regardless of the presence or absence of coma and comorbidities. In addition, we evaluated other outcome indicators and found shorter duration of illness, fever and headache in children with EV in the CPM group. CONCLUSION: Adjunctive CPM therapy may significantly reduce sequelae in children with VE, as well as effectively alleviate patients' clinical symptoms. However, more prospective studies and clinical trials are needed to further evaluate its efficacy and safety.
引用
- Wang P, Chen Y, Wan G, et al. Effects of adjunctive Chinese patent medicine on outcome of viral encephalitis in children: A multicenter retrospective study in China. Phytomedicine. 2023. PMID: 38176272. doi:10.1016/j.phymed.2023.155303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。